Purchase Order 36C26126P0448
- Not listed
- This is a firm-fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, for an automated immunohistochemistry (IHC) and in-situ hybridization (ISH) slide staining system. The contract has a ceiling value of $357,157.72 and a period of performance through March 31, 2026. The system being procured includes instrumentation, reagents, consumables, service, and training for the...
- Roche Diagnostics Corporation has been awarded a delivery order valued at $357,272 for the supply of staining immunohistochemistry (IHC) and in-situ hybridization (ISH) systems, with an ultimate completion date of January 24, 2027. This firm fixed-price contract was awarded without a set-aside designation on January 25, 2026, by Veterans Integrated Service Network 4 (VISN 4), a civilian component of the Department of Veterans Affairs. The work will be performed in Castleton, Indiana, where Roche...
- Roche Diagnostics Corporation has been awarded a $441,795.47 firm fixed-price purchase order by Veterans Integrated Service Network 5 (VISN 5) for immunohistochemical and special stain instrumentation, with performance at a facility in Castleton, Indiana. The contract, awarded September 26, 2025, with an ultimate completion date of September 25, 2030, fulfills a solicitation originally issued by the Department of Veterans Affairs for fully automated immunohistochemical and special staining...
- Roche Diagnostics Corporation, a foreign-owned manufacturer headquartered in Indianapolis, Indiana, was awarded a delivery order by Veterans Integrated Service Network 22 (VISN 22) on January 27, 2026, with an ultimate completion date of January 26, 2027. This contract represents a no-cost line-item addition to an existing $3.1 million Blanket Purchase Agreement for immunohistochemistry and in-situ hybridization equipment and services, with a ceiling value of $38,298.40 under firm fixed-price...
- The Department of Veterans Affairs, Veterans Integrated Service Network (VISN) 16 awarded a firm fixed-price purchase order to Roche Diagnostics Corporation valued at $130,374.85 for the Roche Benchmark Ultra Staining System and Benchmark Special Stains Platform under Exercise Option Year 2. The award, made on November 9, 2023, represents a child contract with an ultimate completion date of November 8, 2028. The equipment will be delivered to Pineville, Louisiana. No set-aside designation was...
- Roche Diagnostics Corporation has been awarded a Purchase Order contract by the Department of Veterans Affairs' Veterans Integrated Service Network 6 for a Benchmark Ultra Annual Service Agreement, valued at approximately $105.8K. The contract, which commenced on January 1, 2025, and extends through December 31, 2029, utilizes firm fixed price pricing with no set-aside designation. This award is a child contract, indicating it likely derives from a larger vehicle such as a GSA Schedule or...
- The Department of Veterans Affairs, Veterans Integrated Service Network 22 (VISN 22), awarded a firm fixed-price purchase order to Roche Diagnostics Corporation for IHC Reagents with a ceiling value of $689,183.79. The contract, awarded on June 12, 2025, will be performed at Roche's facility in Castleton, Indiana, with an ultimate completion date of June 11, 2026. This award carries no set-aside designation, indicating open competition. The contract represents a delivery order against Roche's...
- This is a firm-fixed price purchase order contract awarded by the Department of Veterans Affairs (VA), Veterans Integrated Service Network 10, to Roche Diagnostics Corporation for a standard service plan on a Ventana Benchmark Ultra laboratory system. The contract has a ceiling value of $130,374.85 and a period of performance through April 19, 2028. This contract was awarded on a sole-source basis and was not set aside for any small business program. Roche Diagnostics Corporation is a...
- This is a firm fixed-price delivery order contract awarded by the Veterans Integrated Service Network 4 (VISN 4), a part of the Department of Veterans Affairs (VA), to Roche Diagnostics Corporation for immunohistochemistry laboratory services. The contract has a ceiling value of $432,872.37 and an ultimate completion date of January 24, 2026. Roche Diagnostics, a manufacturer and distributor of in vitro diagnostics, reagents, and laboratory equipment, will provide immunohistochemistry testing...
- The Department of Veterans Affairs (VA) Veterans Health Administration awarded a firm-fixed-price delivery order to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer, for a BENCHMARK SPECIAL STAINS FULL SYSTEM with a potential value of $155,000.00. The contract, which does not have a set-aside designation, is funded through the VA's Veterans Integrated Service Network 16 and was awarded on July 22, 2021 with a completion date of September 30, 2021. Roche Diagnostics provides...
Roche Diagnostics Corporation received a firm fixed-price purchase order valued at $604,880.65 from Veterans Integrated Service Network (VISN) 21, a civilian component of the Department of Veterans Affairs, for clinical immunohistochemistry and in-situ hybridization (IHC/ISH) analyzer services. The contract was awarded on April 1, 2026, without a set-aside designation and will extend through March 31, 2031. This sole-source procurement was designated under Federal Acquisition Regulation 12.102, with the government determining that Roche's BenchMark ULTRA system was the only automated IHC/ISH slide staining system capable of meeting the specific spatial, utility, and operational requirements for the VA Southern Nevada Healthcare System located in Las Vegas, Nevada. The contract will be performed at Roche Diagnostics' facility in Castleton, Indiana. Under this cost-per-test pricing structure, Roche Diagnostics will provide the automated staining analyzer system along with reagents, consumables, and comprehensive support services, including 24/7 telephone support and one-hour on-site response times during business hours. The equipment must operate on existing 110-230V power infrastructure and maintain compliance with accreditation standards from the College of American Pathologists (CAP) and certification requirements under the Clinical Laboratory Improvement Act (CLIA). This award represents an expansion of Roche's existing diagnostic service relationship with VISN 21, which currently operates a $2.5 million indefinite delivery contract for histology staining services through September 2030.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
CPT clinical laboratory immunohistochemistry (IHC) and in-situ hybridization (ISH) analyzer with Reagents | 36C26126Q0338 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 | Solicitation 1/2 | 2/11/26, 11:34 AM | |
CPT clinical laboratory immunohistochemistry (IHC) and in-situ hybridization (ISH) analyzer with Reagents | 36C26126P0448 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 | Award Notice 2/2 | 3/11/26, 11:22 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $121.0k | 3/10/26 |